Tokushima, Japan

Daisuke Mori

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Factory, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daisuke Mori. Retrieved from https://idiyas.com/inventor/daisuke-mori-qyjmrqmp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daisuke Mori: Innovator in Pharmaceutical Chemistry

Introduction

Daisuke Mori is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on phenylimidazole compounds.

Latest Patents

Daisuke Mori holds a patent for a phenylimidazole compound, specifically a phenylimidazole compound of formula (1) and its pharmaceutically acceptable salts. This patent also includes a pharmaceutical composition and a lipoprotein lipase activator that incorporates one of the phenylimidazole compounds.

Career Highlights

Mori is associated with Otsuka Pharmaceutical Factory, Inc., where he has been able to apply his expertise in developing new pharmaceutical solutions. His work has the potential to impact various therapeutic areas, enhancing the efficacy of treatments.

Collaborations

Throughout his career, Daisuke Mori has collaborated with esteemed colleagues such as Koushi Iwata and Tadao Shibutani. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Daisuke Mori's contributions to pharmaceutical chemistry, particularly through his patent on phenylimidazole compounds, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…